BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20068035)

  • 1. Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries.
    Huang YJ; Chen IC; Yu CM; Lee YC; Hsu HJ; Ching AT; Chang HJ; Yang AS
    J Biol Chem; 2010 Mar; 285(11):7880-91. PubMed ID: 20068035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal sequence as a determinant in expressing disulfide-stabilized single chain antibody variable fragments (sc-dsFv) against human VEGF.
    Chen IC; Yu CM; Lee YC; Huang YJ; Hsu HJ; Yang AS
    Mol Biosyst; 2010 Jul; 6(7):1307-15. PubMed ID: 20424732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of signal sequence on phage-displayed disulfide-stabilized single chain antibody variable fragment (sc-dsFv) libraries.
    Lee YC; Chen IC; Yu CM; Huang YJ; Hsu HJ; Yang AS
    Biochem Biophys Res Commun; 2011 Jul; 411(2):348-53. PubMed ID: 21741355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage display of disulfide-stabilized Fv fragments.
    Brinkmann U; Chowdhury PS; Roscoe DM; Pastan I
    J Immunol Methods; 1995 May; 182(1):41-50. PubMed ID: 7769243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.
    Reiter Y; Brinkmann U; Webber KO; Jung SH; Lee B; Pastan I
    Protein Eng; 1994 May; 7(5):697-704. PubMed ID: 8073039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation.
    Reiter Y; Brinkmann U; Jung SH; Pastan I; Lee B
    Protein Eng; 1995 Dec; 8(12):1323-31. PubMed ID: 8869646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A disulfide-stabilized human V
    Henry KA; Kandalaft H; Lowden MJ; Rossotti MA; van Faassen H; Hussack G; Durocher Y; Kim DY; Tanha J
    Mol Immunol; 2017 Oct; 90():190-196. PubMed ID: 28820969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli.
    Schmiedl A; Breitling F; Dübel S
    Protein Eng; 2000 Oct; 13(10):725-34. PubMed ID: 11112512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel human 3-domain disulfide-stabilized antibody fragment against glycoprotein of rabies virus.
    Cai K; Wang H; Bao S; Shi J; Hou X; Gao X; Liu H; Yin J
    Microbes Infect; 2008 Apr; 10(5):548-55. PubMed ID: 18424153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple vector system to improve performance and utilisation of recombinant antibodies.
    Martin CD; Rojas G; Mitchell JN; Vincent KJ; Wu J; McCafferty J; Schofield DJ
    BMC Biotechnol; 2006 Dec; 6():46. PubMed ID: 17156422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of valency in the selection of anti-carbohydrate single-chain Fvs from phage display libraries.
    MacKenzie R; To R
    J Immunol Methods; 1998 Nov; 220(1-2):39-49. PubMed ID: 9839924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display.
    Colby DW; Garg P; Holden T; Chao G; Webster JM; Messer A; Ingram VM; Wittrup KD
    J Mol Biol; 2004 Sep; 342(3):901-12. PubMed ID: 15342245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a phage displayed disulfide-stabilized Fv fragment vaccine against Vibrio anguillarum.
    Xia YJ; Wen WH; Huang WQ; Huang BC
    Vaccine; 2005 May; 23(24):3174-80. PubMed ID: 15837217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
    Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
    J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus.
    ShengFeng C; Ping L; Tao S; Xin W; GuoFeng W
    Vet Res Commun; 2003 Apr; 27(3):243-56. PubMed ID: 12777098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-chain Fv phage display propensity exhibits strong positive correlation with overall expression levels.
    Scott N; Reynolds CB; Wright MJ; Qazi O; Fairweather N; Deonarain MP
    BMC Biotechnol; 2008 Dec; 8():97. PubMed ID: 19113995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique.
    Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U
    Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody scFv fragments without disulfide bonds made by molecular evolution.
    Proba K; Wörn A; Honegger A; Plückthun A
    J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 2. Expression, purification, and characterization of recombinant single chain antibodies.
    Zhang W; Matsumoto-Takasaki A; Kusada Y; Sakaue H; Sakai K; Nakata M; Fujita-Yamaguchi Y
    Biochemistry; 2007 Jan; 46(1):263-70. PubMed ID: 17198397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.
    Zhai W; Davies J; Shang DZ; Chan SW; Allain JP
    J Viral Hepat; 1999 Mar; 6(2):115-24. PubMed ID: 10607222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.